Colorectal cancer (CRC) stands as the second most common cause of cancer-related mortality globally and p53, a widely recognized tumor suppressor, contributes to the development of CRC.

Robyn Gates, a Brownstown resident and registered nurse at Corewell Health, Dearborn, has faced an arduous journey since ...

Fact checked by Nick BlackmerFact checked by Nick Blackmer Rectal bleeding is a symptom commonly seen in colorectal cancer patients, but it's more often caused by more benign causes. When caused by ...

Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial ...

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's internal, ...

This TUNDRA comic was among the humorous images participants viewed in a study that yielded unique findings on the role of ...

Merck & Co Inc (NYSE:MRK) released topline data from the KEYFORM-007 Phase 3 study of the fixed-dose combination of ...

Factors related to sex and gender can affect therapy outcomes and should not be overlooked in clinical practice or research.

"Stool-based test offers a promising solution to reduce the burden of a colonoscopy," experts emphasized on September 21st, ...

Merck follows in the footsteps of Bristol Myers Squibb, which in December 2023 also failed to secure a late-stage victory for ...

A team of epidemiologists at the First Hospital of Hebei Medical University, in China, has shown experimental evidence of an ...

As it works to diversify its methods for catching early cases of colorectal cancer, Exact Sciences has put forward clinical ...